VV extracorporeal life support for the Third Millennium: will we need anticoagulation?

被引：6
作者：
Eytan, Danny [1 ]
Bitterman, Yuval [1 ]
Annich, Gail M. [2 ]
机构：
[1] Rambam Med Ctr, Dept Pediat Crit Care, Haifa, Israel
[2] Univ Toronto, Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
Anticoagulation; unfractionated heparin; direct thrombin inhibitors; surface modification; nitric oxide; endothelialization; HEPARIN-INDUCED THROMBOCYTOPENIA; CARDIOPULMONARY BYPASS CIRCUITS; PROSPECTIVE RANDOMIZED-TRIAL; IN-SITU ENDOTHELIALIZATION; METAL-ORGANIC FRAMEWORKS; NITRIC-OXIDE; MEMBRANE-OXYGENATION; COMPLEMENT ACTIVATION; THROMBIN FORMATION; COATED CIRCUITS;
D O I：
10.21037/jtd.2017.11.89
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Since the late 1600's medicine and science have entertained the idea of extracorporeal circulation. With this technology to allow for cardiac and pulmonary support came the development of anticoagulation. Although this advanced the technology and capabilities of extracorporeal life support, it was not without complications and risks. The most common complications in extracorporeal life support (ECLS) present day are related to hemorrhage and thrombus due to the need for systemic anticoagulation and the challenges associated with it. This review focuses on present day techniques for anticoagulation for ECLS and what future surface modifications may do to obviate the use of systemic anticoagulation entirely.
引用
收藏
页码：S698 / S706
页数：9
相关论文
共 88 条
  • [1] Al-Sa'doni HH, 2004, CURR MED CHEM, V11, P2679
  • [2] Thromboprophylaxis in Extracorporeal Circuits: Current Pharmacological Strategies and Future Directions
    Annich, Gail M.
    Zaulan, Oshri
    Neufeld, Megan
    Wagner, Deborah
    Reynolds, Melissa M.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (06) : 425 - 439
  • [3] Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization - A review of current strategies
    Avci-Adali, Meltem
    Ziemer, Gerhard
    Wendel, Hans P.
    [J]. BIOTECHNOLOGY ADVANCES, 2010, 28 (01) : 119 - 129
  • [4] Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations
    Bain, Jonathan
    Flannery, Alexander H.
    Flynn, Jeremy
    Dager, William
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 44 (01) : 76 - 87
  • [5] Bauer Adrian, 2010, J Extra Corpor Technol, V42, P30
  • [6] Argatroban in extracorporeal membrane oxygenation
    Beiderlinden, Martin
    Treschan, Tanja
    Goerlinger, Klaus
    Peters, Juergen
    [J]. ARTIFICIAL ORGANS, 2007, 31 (06) : 461 - 465
  • [7] Variability in Anticoagulation Management of Patients on Extracorporeal Membrane Oxygenation: An International Survey
    Bembea, Melania M.
    Annich, Gail
    Rycus, Peter
    Oldenburg, Gary
    Berkowitz, Ivor
    Pronovost, Peter
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (02) : E77 - E84
  • [8] Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants
    Böning, A
    Scheewe, J
    Ivers, T
    Friedrich, C
    Stieh, J
    Freitag, S
    Cremer, JT
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (05) : 1458 - 1465
  • [9] Chinn J. A., 2000, BIOMED ENG HDB BOCA, V200, P1597
  • [10] Anticoagulation for Extracorporeal Life Support: Direct Thrombin Inhibitors and Heparin
    Coughlin, Megan A.
    Bartlett, Robert H.
    [J]. ASAIO JOURNAL, 2015, 61 (06) : 652 - 655
123456789